Welcome to Viventia Biotech Inc.

Viventia Biotech Inc. is a privately held biopharmaceutical company specializing in the discovery and development of a new generation of advanced monoclonal antibody products designed to offer safer, more beneficial therapies for those who suffer from cancer. Viventia is employing its novel monoclonal antibody discovery and development platforms to discover, validate and advance a portfolio of new antibody products based on proprietary oncology drug targets.



Copyright 2007 © Viventia Biotech Inc. All rights reserved.
The content of this site is for informational purposes only and is not intended to replace the advice of a health care professional.
Please consult your doctor if you have any questions regarding the information contained in this site.
Viventia, the Viventia logo, Proxinium, Vicinium, Unlock, Immunomine, Fusogenics, Power + Precision and Armed Antibodies are
Trade Marks of Viventia Biotech Inc.